RZLT

Rezolute, Inc.

There isn't enough reported data to score RZLT yet.

RZLT Fundamentals

MetricStatus
Unavailable
Under pressure
Unavailable
Unavailable

RZLT's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.

RZLT PE Valuation

RZLT has no meaningful PE right now: it lost money over the past year.

RZLT Forward outlook

MetricOutlook
--
Losses steady
Strong growth
--
Limited
Moderate

Analysts expect RZLT's revenue to grow, with its earnings and profitability holding steady.

RZLT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $3.87 on Nov 12.

There is not enough scenario data to assess RZLT's risk to reward.

RZLT Earnings Per Share

Q4 2023: $-1.11Q1 2024: $-1.15Q2 2024: $-1.33Q3 2024: $-1.27Q4 2024: $-1.22Q1 2025: $-1.15Q2 2025: $-0.98Q3 2025: $-0.94Q4 2025: $-0.94Q1 2026: $-0.83Q2 2026: $-0.75Q3 2026: $-0.75
Q4 2023: $-1.11Q1 2024: $-1.15Q2 2024: $-1.33Q3 2024: $-1.27Q4 2024: $-1.22Q1 2025: $-1.15Q2 2025: $-0.98Q3 2025: $-0.94Q4 2025: $-0.94Q1 2026: $-0.83Q2 2026: $-0.75Q3 2026: $-0.75
QuarterTTM EPSYoY
Q3 2026-$0.75+$0.19
Q2 2026-$0.75+$0.23
Q1 2026-$0.83+$0.32
Q4 2025-$0.94+$0.28
Q3 2025-$0.94+$0.33
Q2 2025-$0.98+$0.35
Q1 2025-$1.15$0.00
Q4 2024-$1.22-$0.11

RZLT is still losing money, but less than at its worst: $0.75 per share over the past year, against $1.33 at its worst in mid-2024.

RZLT Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

RZLT Free Cash Flow

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: −$16MQ4 2024: −$14MQ1 2025: −$17MQ2 2025: −$22MQ3 2025: −$17MQ4 2025: −$20MQ1 2026: −$14MQ2 2026: −$13MQ3 2026: −$19M
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: −$16MQ4 2024: −$14MQ1 2025: −$17MQ2 2025: −$22MQ3 2025: −$17MQ4 2025: −$20MQ1 2026: −$14MQ2 2026: −$13MQ3 2026: −$19M
QuarterFree cash flowYoY
Q3 2026-$18.8M-$1.4M
Q2 2026-$13.1M+$8.8M
Q1 2026-$13.7M+$3.7M
Q4 2025-$20.3M-$6.7M
Q3 2025-$17.4M-$1.4M
Q2 2023-$11.4M+$760K
Q1 2023-$18M-$4.1M
Q4 2022-$7.6M-$379K

RZLT has burned cash in almost every quarter: −$66M over the past year, against −$70M the year before.

RZLT Total Shares

Q4 2023: 51MQ1 2024: 51MQ2 2024: 51MQ3 2024: 70MQ4 2024: 70MQ1 2025: 70MQ2 2025: 76MQ3 2025: 103MQ4 2025: 104MQ1 2026: 104MQ2 2026: 104MQ3 2026: 105M
Q4 2023: 51MQ1 2024: 51MQ2 2024: 51MQ3 2024: 70MQ4 2024: 70MQ1 2025: 70MQ2 2025: 76MQ3 2025: 103MQ4 2025: 104MQ1 2026: 104MQ2 2026: 104MQ3 2026: 105M
PeriodChange %Net change
Quarterly+0.8%+870K shares
1 year+1.3%+1.4M shares
3 years+104%+53.4M shares

RZLT has 105M diluted shares, up 1.3% from a year ago.

RZLT Net Leverage

RZLT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

RZLT Weekly Momentum

MetricValueStatus
RSI46.3Neutral
Stochastic23.4Neutral

RZLT's weekly RSI is 46 (neutral) and its Stochastic is 23 (neutral).

RZLT PE vs Healthcare Sector

RZLT has no meaningful PE right now: it lost money over the past year.

RZLT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.993% below
20 week MA$4.3812% below
50 week MA$3.831% above
100 week MA$4.7719% below
200 week MA$3.714.3% above

RZLT's trend is mixed: it's above two of its five weekly moving averages, and 4.3% above its 200-week average.

RZLT Yearly ROI

YearStart priceEnd priceROI
2020$6.50$15.3+135%
2021$15.3$4.66-70%
2022$4.66$2.08-55%
2023$2.08$0.99-52%
2024$0.99$4.96+401%
2025$4.96$2.67-46%
2026 YTD$2.67$3.87+45%

RZLT's yearly returns have swung widely, from +401% in 2024 to −70% in 2021. It's up 45% so far in 2026.

Give your agent the market.

Get API key